[1]
Mothilal, M. et al. 2014. FORMULATION AND EVALUATION OF NAPROXEN-EUDRAGIT® RS 100 NANOSUSPENSION USING 32 FACTORIAL DESIGN. International Journal of Pharmacy and Pharmaceutical Sciences. 6, 7 (Jul. 2014), 449–455.